Last updated: January 3, 2023
Sponsor: Indonesia University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hair Loss
Alopecia
Treatment
N/AClinical Study ID
NCT05681897
876/UN2.F1/ETIK/PPM.00.02/2
Ages 25-59 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Met the criteria of androgenic alopecia (Hamilton Norwood grade III-IV)
- Men between ages 25-59 years old
- Have stopped taking topical anti-androgen or minoxidil for at least one month, or oralanti-androgen or minoxidil for at least three months
Exclusion
Exclusion Criteria:
- alopecia of any other type
- subject with a history of keloid or blood coagulation disorders underwentanticoagulant therapy
- subjects on Non-Steroidal Anti-Inflammatory Drugs (NSAID) medications in seven daysprior to the study
- subjects who had hair treatment using growth factors, including PRP and microneedlingwithin at least six months prior to the study.
Study Design
Total Participants: 30
Study Start date:
February 01, 2023
Estimated Completion Date:
February 28, 2023
Study Description
Connect with a study center
Cipto Mangunkusumo General Hospital
Jakarta Pusat, DKI Jakarta 10430
IndonesiaActive - Recruiting
Universitas Indonesia
Jakarta Pusat, Jakarta 10430
IndonesiaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.